Nemaura Medical Reports Results and Provides Business Update for the Third Quarter Ended December 31, 2019
February 11, 2020 09:00 ET
|
Nemaura Medical Inc
Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible...
Nemaura Provides 2019 Year-End Corporate Update
December 20, 2019 09:00 ET
|
Nemaura Medical Inc
Loughborough, England, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous...
Nemaura Medical and Changing Health announce Partnership to provide award-winning Diabetes Behavioral Change services
December 17, 2019 09:15 ET
|
Nemaura Medical Inc
Loughborough, England, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible...
Nemaura Medical announces expansion of SugarBEAT® offering with BEAT® Diabetes digital subscription services
December 05, 2019 08:30 ET
|
Nemaura Medical Inc
Loughborough, England, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ:NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a...
Nemaura Medical Announces 1 for 10 Reverse Split Intended to Attract a Wider Universe of Institutional Investors
December 04, 2019 10:00 ET
|
Nemaura Medical Inc
Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a...
Nemaura Medical Reports Results and Provides Business Update for the Second Quarter Ended September 30, 2019
November 11, 2019 09:00 ET
|
Nemaura Medical Inc
Loughborough, England, Nov. 11, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a...
Nemaura Medical Provides Update Regarding Commercial Launch of SugarBEAT® and First Patient User Experiences as Presented at EASD Symposia 2019 in Barcelona
October 03, 2019 09:00 ET
|
Nemaura Medical Inc
Loughborough, England, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a...
Nemaura Medical to Hold a Symposia at EASD in Barcelona on Thursday September 19, 2019
September 12, 2019 09:15 ET
|
Nemaura Medical Inc
Loughborough, England , Sept. 12, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – September 12, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the...
Nemaura Medical Reports Quarterly Results for First Quarter Ended June 30, 2019
August 09, 2019 13:30 ET
|
Nemaura Medical Inc
Loughborough, England, Aug. 09, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a...
Nemaura Medical Announces First Shipments of SugarBEAT® Devices to Diabetic and Pre-Diabetic Patients as Part of its First Phase of Launch
August 07, 2019 08:30 ET
|
Nemaura Medical Inc
Loughborough, England, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive,...